| 2013 | A multicenter, phase II trial of everolimus in locally advanced or metastatic thyroid cancer of all histologic subtypes | ANNALS OF ONCOLOGY |
| 2013 | A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC) | LUNG CANCER |
| 2010 | Acquired resistance to cetuximab is mediated by increased PTEN instability and leads cross-resistance to gefitinib in HCC827 NSCLC cells. | CANCER LETTERS |
| 2012 | Activation of IL-6R/JAK1/STAT3 signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation | MOLECULAR CANCER THERAPEUTICS |
| 2012 | Additional diagnostic value of tumor markers in cytological fluid for diagnosis of non-small-cell lung cancer
| BMC CANCER |
| 2005 | ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis | CANCER GENE THERAPY |
| 2015 | Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma
| MOLECULAR CANCER THERAPEUTICS |
| 2014 | Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma | LUNG CANCER |
| 2005 | Coxsackie and adenovirus receptor binding ablation reduces adenovirus liver tropism and toxicity | HUMAN GENE THERAPY |
| 2012 | Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.
| CANCER |
| 2009 | Double E1B 19 kDa- and E1B 55 kDa-deleted oncolytic adenovirus in combination with radiotherapy elicits an enhanced anti-tumor effect | GENE THERAPY |
| 2007 | E1A- and E1B-double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects | HUMAN GENE THERAPY |
| 2005 | E1A/E1B 이중변이형 종양 선택적 살상 아데노바이러스의 개선된 암세포 살상 효과 및 항종양 효과
| Journal of Bacteriology and Virology |
| 2012 | Efficacy and toxicity of belotecan for relapsed or refractory small cell lung cancer patients | JOURNAL OF THORACIC ONCOLOGY |
| 2012 | EGFR polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI
| YONSEI MEDICAL JOURNAL |
| 2013 | Glycolysis Inhibition Sensitizes Non–Small Cell Lung Cancer with T790M Mutation to Irreversible EGFR Inhibitors via Translational Suppression of Mcl-1 by AMPK Activation | MOLECULAR CANCER THERAPEUTICS |
| 2007 | Hybrid nanoparticles for magnetic resonance imaging of target-specific viral gene delivery | ADVANCED MATERIALS |
| 2014 | Impact of cigarette smoking on response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations | LUNG CANCER |
| 2011 | MEKK1/MEKK4 are responsible for TRAIL-induced JNK/p38 phosphorylation
| ONCOLOGY REPORTS |
| 2008 | Novel cancer antiangiotherapy using the VEGF promoter-targeted artificial zinc-finger protein and oncolytic adenovirus | MOLECULAR THERAPY |
| 2013 | Pharmacogenomic Assessment of Outcomes of Pemetrexed-Treated Patients with Adenocarcinoma of the Lung
| YONSEI MEDICAL JOURNAL |
| 2015 | Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck | CLINICAL CANCER RESEARCH |
| 2008 | Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition | GENE THERAPY |
| 2012 | The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma. | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2013 | The Impact of Cigarette Smoking on the Frequency of and Qualitative Differences in KRAS Mutations in Korean Patients with Lung Adenocarcinoma
| YONSEI MEDICAL JOURNAL |
| 2010 | Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL
| MOLECULAR THERAPY |
| 2011 | TRAIL-induced caspase/p38 activation is responsible for the increased catalytic and invasive activities of Akt
| INTERNATIONAL JOURNAL OF ONCOLOGY |
| 2007 | VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth | MOLECULAR THERAPY |
